Diabetes mellitus and cerebral stroke: a modern look at the problem

Main Article Content

N.V. Pashkovska
V.M. Pashkovskyy


The article presents modern information on epidemiology and risk factors for acute cerebrovascular accidents in patients with diabetes mellitus. The literature data are provided on possible mechanisms of diabetic cerebral disorders. The questions of diagnostic features, differential diagnosis, treatment and prevention of cerebral strokes in patients with diabetes mellitus according to modern clinical guidelines are discussed.

Article Details

How to Cite
Pashkovska, N., and V. Pashkovskyy. “Diabetes Mellitus and Cerebral Stroke: A Modern Look at the Problem”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), vol. 14, no. 4, Aug. 2018, pp. 298-09, doi:10.22141/2224-0721.14.4.2018.140181.
Leading Article


Mishchenko TS. Epidemiology of cerebrovascular diseases and organization of medical care for patients with stroke in Ukraine. Ukrains'kyi visnyk psykhonevrolohii. 2017;25(1):22-24. (in Ukrainian).

Feigin VL, Forouzanfar MH, Krishnamurthi R, et al. Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet. 2014;383(9913):245-254.

Zozulia YuP, Mishchenko TS. Problems of angio-cerebrum pathology and their management. Zhurn. HAMN Ukrainy. 2011;17(1):19-25. (in Ukrainian).

Mishchenko TS. Problems of nervous system pathology in Ukraine and the state of the domestic neurological service at the border of the decade. Zdorov`a Ukrai'ny. 2010;(14):3-4. (in Ukrainian).

Cho NH, Shaw JE, Karuranga S, et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018 Apr;138:271-281. doi: 10.1016/j.diabres.2018.02.023.

Tun NN, Arunagirinathan G, Munshi SK, Pappachan JM. Diabetes mellitus and stroke: A clinical update. World J Diabetes. 2017 Jun 15;8(6):235-248. doi: 10.4239/wjd.v8.i6.235.

Lee M, Saver JL, Hong K-S, Song S, Chang KH, Ovbiagele B. Effect of pre-diabetes on future risk of stroke: meta-analysis. The BMJ. 2012;344:e3564. doi:10.1136/bmj.e3564.

Dutton GR, Lewis CE. The Look AHEAD Trial: Implications for Lifestyle Intervention in Type 2 Diabetes Mellitus. Prog Cardiovasc Dis. 2015 Jul-Aug;58(1):69-75. doi: 10.1016/j.pcad.2015.04.002.

Jørgensen H, Nakayama H, Raaschou HO, Olsen TS. Stroke in patients with diabetes. The Copenhagen Stroke Study. Stroke. 1994 Oct;25(10):1977-84.

Najarian RM, Sullivan LM, Kannel WB, Wilson PW, D'Agostino RB, Wolf PA. Metabolic syndrome compared with type 2 diabetes mellitus as a risk factor for stroke: the Framingham Offspring Study. Arch Intern Med. 2006 Jan 9;166(1):106-11. DOI: 10.1001/archinte.166.1.106.

Chen R, Ovbiagele B, Feng W. Diabetes and Stroke: Epidemiology, Pathophysiology, Pharmaceuticals and Outcomes. Am J Med Sci. 2016 Apr;351(4):380-6. doi: 10.1016/j.amjms.2016.01.011.

Brownlee M. Te pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005 Jun;54(6):1615-25. doi:10.2337/diabetes.54.6.1615.

Solovieva EY, Farrahova KI, Karneev AN, Chipova DT. Phospholipids metabolism disorders in acute stroke. Zhurnal nevrologii i psikhiatrii imeni SS Korsakova. 2016;116(1):104-112. doi: 10.17116/jnevro201611611104-112.

Frimat M, Daroux M, Litke R, Nevière R, Tessier FJ, Boulanger E. Kidney, heart and brain: three organs targeted by ageing and glycation. Clin Sci (Lond). 2017 Jun 1;131(11):1069-1092. doi: 10.1042/CS20160823.

Yan L-J. Redox imbalance stress in diabetes mellitus: Role of the polyol pathway. Animal Model Exp Med. 2018 Mar;1(1):7-13. doi: 10.1002/ame2.12001.

Hamed hSA. Brain injury with diabetes mellitus: evidence, mechanisms and treatment implications. Expert Rev Clin Pharmacol. 2017 Apr;10(4):409-428. doi: 10.1080/17512433.2017.1293521.

Li W, Abdul Y, Ward R, et al. Endothelin and diabetic complications: a brain-centric view. Physiol Res. 2018 Jun 27;67(Supplementum 1):S83-S94.

Paneni F, Beckman JA, Creager MA, Cosentino F. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur Heart J. 2013 Aug;34(31):2436-43. doi: 10.1093/eurheartj/eht149.

Etchegoyen M, Nobile MH, Baez F, et al. Metabolic Syndrome and Neuroprotection. Front Neurosci. 2018 Apr 20;12:196. doi: 10.3389/fnins.2018.00196.

Pruzin JJ, Nelson PT, Abner EL, Arvanitakis Z. Review: Relationship of type 2 diabetes to human brain pathology. Neuropathol Appl Neurobiol. 2018;44(4):347-362. doi: 10.1111/nan.12476.

Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA.10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008 Oct 9;359(15):1577-89. doi: 10.1056/NEJMoa0806470.

Huxley RR, Filion KB, Konety S, Alonso A. Meta-analysis of Cohort and Case-Control Studies of Type-2 Diabetes Mellitus and Risk of Atrial Fibrillation. Am J Cardiol. 2011 Jul 1;108(1):56-62. doi: 10.1016/j.amjcard.2011.03.004.

Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991 Aug;22(8):983-8.

Melgaard L, Gorst-Rasmussen A, Søgaard P, Rasmussen LH, Lip GY, Larsen TB. Diabetes mellitus and risk of ischemic stroke in patients with heart failure and no atrial fibrillation. Int J Cardiol. 2016 Apr 15;209:1-6. doi: 10.1016/j.ijcard.2016.02.004.

Shou J, Zhou L, Zhu S, Zhang X. Diabetes is an Independent Risk Factor for Stroke Recurrence in Stroke Patients: A Meta-analysis. J Stroke Cerebrovasc Dis. 2015 Sep;24(9):1961-8. doi: 10.1016/j.jstrokecerebrovasdis.2015.04.004.

Karsito, Soeatmadji DW. Diabetes and stroke. Acta Med Indones. 2008 Jul;40(3):151-8.

Tuttolomondo A, Pinto A, Salemi G, et al. Diabetic and non-diabetic subjects with ischemic stroke: differences, subtype distribution and outcome. Nutr Metab Cardiovasc Dis. 2008 Feb;18(2):152-7. doi: 10.1016/j.numecd.2007.02.003.

Bangen KJ, Gu Y, Gross AL, et al. Relationship Between Type 2 Diabetes Mellitus and Cognitive Change in a Multiethnic Elderly Cohort. J Am Geriatr Soc. 2015 Jun;63(6):1075-83. doi: 10.1111/jgs.13441.

Batyisheva TT, Ryizhak AA, Novikova LA. Features of acute cerebrovascular accident in patients with diabetes mellitus. Lechaschii Vrach. 2004;(1):70-72. (in Russian).

Pashkovska NV. Features of clinical motion of acute cerebrovascular accident in patients with diabetes mellitus. Bukovinian Medical Herald. 2007;(3):58-61. (in Ukrainian).

Sander D, Kearney MT. Reducing the risk of stroke in type 2 diabetes: pathophysiological and therapeutic perspectives. J Neurol. 2009 Oct;256(10):1603-19. doi: 10.1007/s00415-009-5143-1.

Weir CJ, Murray GD, Dyker AG, Lees KR. Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study. BMJ. 1997 May 3;314(7090):1303-6.

Hankey GJ, Anderson NE, Ting RD, et al. Rates and predictors of risk of stroke and its subtypes in diabetes: a prospective observational study. J Neurol Neurosurg Psychiatry. 2013 Mar;84(3):281-7. doi: 10.1136/jnnp-2012-303365.

Bowen A, James M, Young G, editors; Intercollegiate Stroke Working Party. National clinical guideline for stroke, 5th ed. London: Royal College of Physicians, 2016. 178 p.

Olsen TS, Langhorne P, Diener HC, et al. European Stroke Initiative Recommendations for Stroke Management-update 2003. Cerebrovasc Dis. 2003;16(4):311-37. doi: 10.1159/000072554.

Van Harten B, De leeuw FE, Weinstein HC, Scheltens P, Biessels GJ. Brain imaging in patients with diabetes: a systematic review. Diabetes Care. 2006 Nov;29(11):2539-48. doi: 10.2337/dc06-1637.

Davis WA, Colagiuri S, Davis TM. Comparison of the Framingham and United Kingdom Prospective Diabetes Study cardiovascular risk equations in Australian patients with type 2 diabetes from the Fremantle Diabetes Study. Med J Aust. 2009 Feb 16;190(4):180-4.

Bruno A, Kent TA, Coull BM, et al. Treatment of hyperglycemia in ischemic stroke (THIS): a randomized pilot trial. Stroke. 2008 Feb;39(2):384-9. doi: 10.1161/STROKEAHA.107.493544.

Levin DL. Cerebral edema in diabetic ketoacidosis. Pediatr Crit Care Med. 2008 May;9(3):320-9. doi: 10.1097/PCC.0b013e31816c7082.

Radermecker RR, Philips JC, Jandrain BJ, Paquot N, Lefèbvre PJ, Scheen AJ. Brain, a gluco-dependent organ: toxic effects of hypoglycaemia and hyperglycaemia. Rev Med Liege. 2008 May-Jun;63(5-6):280-6. (in French).

Ahmed N, Steiner T, Caso V, Wahlgren N, ESO-KSU session participants. Recommendations from the ESO-Karolinska Stroke Update Conference, Stockholm 13–15 November 2016. Eur Stroke J. 2017 Jun;2(2):95-102. doi: 10.1177/2396987317699144.

Lu GD, Ren ZQ, Zhang JX, Zu QQ, Shi HB. Effects of Diabetes Mellitus and Admission Glucose in Patients Receiving Mechanical Thrombectomy: A Systematic Review and Meta-analysis. Neurocrit Care. 2018 Jun 26. doi: 10.1007/s12028-018-0562-4.

Pankiv VI. Current management of carbohydrate metabolism in patients with diabetes mellitus and disorders of brain circulation. Ratsionalna farmakoterapiia. 2009;1(0):15-20. (in Ukrainian).

Fuentes B, Ntaios G, Putaala J, et al. European Stroke Organisation (ESO) guidelines on glycaemia management in acute stroke. European Stroke Journal. 2017;3(1):5-21. doi: 10.1177/2396987317742065.

Powers WJ, Rabinstein AA, Ackerson T, et al. 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2018 Mar;49(3):e46-e110. doi: 10.1161/STR.0000000000000158.

Johnston KC, Hall CE, Kissela BM, Bleck TP, Conaway MR; GRASP Investigators. Glucose regulation in acute stroke patients (GRASP) trial a randomized pilot trial. Stroke. 2009 Dec;40(12):3804-9. doi: 10.1161/STROKEAHA.109.561498.

Poppe AY, Majumdar SR, Jeerakathil T, et al. Admission Hyperglycemia Predicts a Worse Outcome in Stroke Patients Treated With Intravenous Thrombolysis. Diabetes Care. 2009 Apr;32(4):617-22. doi: 10.2337/dc08-1754.

Gray CS, Hildreth AJ, Sandercock PA, et al. Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK). Lancet Neurol. 2007 May;6(5):397-406. doi: 10.1016/S1474-4422(07)70080-7.

Bellolio MF, Gilmore RM, Ganti L. Insulin for glycaemic control in acute ischaemic stroke. Cochrane Database Syst Rev. 2014 Jan 23;(1):CD005346. doi: 10.1002/14651858.CD005346.pub4.

Jauch EC, Saver JL, Adams HP, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(3):870-947. doi: 10.1161/STR.0b013e318284056a.

Hemphill JC, 3rd, Greenberg SM, Anderson CS, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015 Jul;46(7):2032-60. doi: 10.1161/STR.0000000000000069.

Maahs DM, Daniels SR, de Ferranti SD, et al. Cardiovascular disease risk factors in youth with diabetes mellitus: a scientific statement from the American Heart Association. Circulation. 2014 Oct 21;130(17):1532-58. doi: 10.1161/CIR.0000000000000094.

Liebson PR. Diabetes control and cardiovascular risk, Part II: Intensive glucose control-UKPDS follow-up. Prev Cardiol. 2009 Winter;12(1):51-8.

Mankovskiy BN. Stroke and diabetes mellitus: point of view of endocrinologist. Zdorov`a Ukra`iny. 2011;1(15):38-39. (in Russian).

Ceriello A, Ihnat MA, Thorpe JE. Clinical review 2: The “metabolic memory”: is more than just tight glucose control necessary to prevent diabetic complications? J Clin Endocrinol Metab. 2009 Feb;94(2):410-5. doi: 10.1210/jc.2008-1824.

Orchard TJ, Nathan DM, Zinman B, et al. Association between 7 years of intensive treatment of type 1 diabetes and long term mortality. JAMA. 2015;313(1):45-53. doi:10.1001/jama.2014.16107.

Fox CS, Golden SH, Anderson C, et al. Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association. Diabetes Care. 2015 Sep;38(9):1777-803. doi: 10.2337/dci15-0012.

Zaccardi F, Pitocco D, Ghirlanda G. Glycemic risk factors of diabetic vascular complications: the role of glycemic variability. Diabetes Metab Res Rev. 2009;25(3):199-207. doi: 10.1002/dmrr.938.

Tkác I. Effect of intensive glycemic control on cardiovascular outcomes and all-cause mortality in type 2 diabetes: Overview and metaanalysis of five trials. Diabetes Res Clin Pract. 2009 Dec;86 Suppl 1:S57-62. doi: 10.1016/S0168-8227(09)70011-7.

American Diabetes Association. Glycemic Targets: Standards of Medical Care in Diabetes – 2018 American Diabetes Association Diabetes Care. 2018 Jan;41(Suppl 1):S55-S64. doi: 10.2337/dc18-S006.

González Hernández A, Fabre pi O, López Fernández JC, et al. Risk factors, etiology and prognosis in patients with ischemic stroke and diabetes mellitus. Rev Clin Esp. 2008;208(11):546-50. (in Spanish).

The ACCORD Study Group, Cushman WC, Evans GW, Byington RP, et al. Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus. N Engl J Med. 2010 Apr 29;362(17):1575-85. doi: 10.1056/NEJMoa1001286.

Bangalore S, Kumar S, Lobach I, Messerli FH. Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: observations from traditional and bayesian random-effects meta-analyses of randomized trials. Circulation. 2011 Jun 21;123(24):2799-2810. doi: 10.1161/CIRCULATIONAHA.110.016337.

Davis WA, Colagiuri S, Davis TM. Comparison of the Framingham and United Kingdom Prospective Diabetes Study cardiovascular risk equations in Australian patients with type 2 diabetes from the Fremantle Diabetes Study. Med J Aust. 2009 Feb 16;190(4):180-4.

Usharani P, Mateen AA, Naidu MU, Raju YS, Chandra N. Effect of NCB-02, atorvastatin and placebo on endothelial function, oxidative stress and inflammatory markers in patients with type 2 diabetes mellitus: a randomized, parallel-group, placebo-controlled, 8-week study. Drugs R D. 2008;9(4):243-50.

Miettinen TA, Gylling H. Blood glucose and the metabolism of cholesterol in coronary patients with and without simvastatin treatment. Clin Chim Acta. 2007;379(1-2):53-8. doi: 10.1016/j.cca.2006.12.011.

Cui J, Forbes A, Kirby A, et al. Semi-parametric risk prediction models for recurrent cardiovascular events in the LIPID study. BMC Med Res Methodol. 2010 Apr 1;10:27. doi: 10.1186/1471-2288-10-27.

Hu M, Tomlinson B. Current Perspectives on rosuvastatin. Integr Blood Press Control. 2013 Apr 18;6:15-25. doi: 10.2147/IBPC.S34814.

Charlton-Menys V, Betteridge DJ, Colhoun H, et al. Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: the Collaborative Atorvastatin Diabetes Study (CARDS). Diabetologia. 2009;52(2):218-25. doi: 10.1007/s00125-008-1176-8.

Cannon CP, Blazing MA, Giugliano RP, et al. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. N Engl J Med. 2015;372(25):2387-97. doi:10.1056/NEJM199710303371801.

Keech A, Simes RJ, Barter P, et al. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomized controlled trial. Lancet. 2005 Nov 26;366(9500):1849-61. doi: 10.1016/S0140-6736(05)67667-2.

CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet. 1996 Nov 16;348(9038):1329-39.

Wang Y, Wang Y, Zhao X, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med. 2013 Jul 4;369(1):11-9. doi: 10.1056/NEJMoa1215340.

Palacio S, Hart RG, Pearce LA, et al. Effect of addition of clopidogrel to aspirin on stroke incidence: Meta-analysis of randomized trials. Int J Stroke. 2015 Jul;10(5):686-91. doi: 10.1111/ijs.12050.

Pappachan JM, Viswanath AK. Medical Management of Diabesity: Do We Have Realistic Targets? Curr Diab Rep. 2017 Jan;17(1):4. doi: 10.1007/s11892-017-0828-9.

Rubino F, Nathan DM, Eckel RH, et al. Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations. Diabetes Care. 2016 Jun;39(6):861-77. doi: 10.2337/dc16-0236.

Most read articles by the same author(s)

1 2 3 4 > >>